• Corpus ID: 24105382

High prevalence of hypogonadotropic hypogonadism in men referred for obesity treatment.

@article{Hofstra2008HighPO,
  title={High prevalence of hypogonadotropic hypogonadism in men referred for obesity treatment.},
  author={Julia M. Hofstra and Sandra Loves and Bas van Wageningen and Janneke Ruinemans-Koerts and Irmelin Jansen and Hans de Boer},
  journal={The Netherlands journal of medicine},
  year={2008},
  volume={66 3},
  pages={
          103-9
        }
}
BACKGROUND Obesity can be associated with biochemical evidence of isolated hypogonadotropic hypogonadism (IHH) in men. Prevalence and severity of IHH in obese men are not exactly known. OBJECTIVE To assess the prevalence of IHH in obese men. DESIGN AND SUBJECTS Cross-sectional study of 160 obese men, BMI >30 kg/m2, who applied for medical or surgical treatment of obesity in a general teaching hospital. MAIN OUTCOME MEASURES Total and calculated free testosterone (TT and FT) in relation to… 

Tables from this paper

Prevalence of Hypogonadism in a Male Population below 60 Years of Age with Metabolic Syndrome
TLDR
A high prevalence of H is found using T and cfT in Chilean patients with MetS below 60 years of age, who turned out to be more insulin-resistant and have more visceral fat, waist, and E2 than non-H.
Prevalence of male secondary hypogonadism in moderate to severe obesity and its relationship with insulin resistance and excess body weight
TLDR
The data show the prevalence of MOSH in patients with moderate to severe obesity is high and low circulating testosterone is associated with insulin resistance and low ejaculate volume with higher BMI and excess body weight.
Secondary male hypogonadism: a prevalent but overlooked comorbidity of obesity
TLDR
Weight loss and treatment to replace testosterone levels improve the metabolic profile and quality of life in patients with obesity and hypogonadism; these beneficial effects depend on treatment modality and duration of therapy.
Hypogonadotropic Hypogonadism in Morbidly Obese Males Is Reversed After Bariatric Surgery
TLDR
Obesity-associated hypogonadism is very prevalent in males with morbid obesity and is mostly reversed after sustained weight loss by bariatric surgery.
Hypogonadotropic Hypogonadism in Men With Diabesity
TLDR
Testosterone replacement therapy results in a loss of fat mass, gain in lean mass, and increase in insulin sensitivity in men with diabesity and HH, and there is also an improvement in sexual symptoms, anemia, LDL cholesterol, and lipoprotein, however, testosterone therapy does not consistently affect HbA1c inMen with diabetes.
Hypogonadotropic Hypogonadism in Men with Type 2 Diabetes
TLDR
Clinical trials are required to determine whether testosterone replacement therapy alleviates insulin resistance, inflammation, and symptoms related to sexual dysfunction care, and the pathophysiology of hypog onadotropic hypogonadism in men with type 2 diabetes and its signs and symptoms.
Hypogonadism in a male‐to‐female transsexual with super obesity
TLDR
It is anticipated that similar cases of hypogonadism in male‐to‐female transsexuals will likely become more common in an era of increased obesity rates.
Reversal of idiopathic hypogonadotropic hypogonadism: a cohort study in Chinese patients
TLDR
The finding suggests that reversible patients may retain partially active reproductive axis function at initial diagnosis, and larger testicle size and higher stimulated LH concentrations are favorite parameters for reversal.
Testosterone Concentrations in Diabetic and Nondiabetic Obese Men
TLDR
Obesity is probably the condition most frequently associated with subnormal free testosterone concentrations in males and the concomitant presence of diabetes is associated with an additional increase in the prevalence of subnormalFree testosterone concentrations.
...
...

References

SHOWING 1-10 OF 56 REFERENCES
Diagnosis of hypogonadism in the aging male
  • A. Vermeulen, J. Kaufman
  • Medicine, Biology
    The aging male : the official journal of the International Society for the Study of the Aging Male
  • 2002
TLDR
In the absence of convincing arguments for altered requirements with age, it is considered that the normal range of (free) testosterone levels in young adults is also valid for elderly men, the lower normal limit being 11 nmol/l for total testosterone and 0.225 nmol for free testosterone.
Effect of massive weight loss on hypothalamic-pituitary-gonadal function in obese men.
TLDR
A change in hypothalamic-pituitary function with weight loss is postulated, such that GnRH-gonadotropin secretion becomes less sensitive to suppression by a given amount of estrogen.
Decreased pituitary-gonadal secretion in men with obstructive sleep apnea.
TLDR
The findings suggest that OSA in men is associated with dysfunction of the pituitary-gonadal axis and sleep fragmentation and, to a lesser extent, hypoxia in addition to the degree of obesity and aging may be responsible for the central suppression of testosterone in these patients.
Pathogenesis of the decreased androgen levels in obese men.
TLDR
Even in massively obese subjects with decreased FT levels, androgen metabolism and 5 alpha-reductase activity appeared to be normal, as suggested by similar androstanediol glucuronide and AG levels, determined by RIA or calculated from the conversion rates of precursors obtained in nonobese subjects.
Low serum testosterone and sex-hormone-binding-globulin in massively obese men.
TLDR
Reproductive hormonal dynamics were assessed in 10 massively obese men, 200–380% of ideal body weight and 11 similarly-aged controls who were 85–135% of Ideal body weight to find out if these subjects had normal secondary sexual characteristics.
The effect of weight loss on reproductive hormones in obese men.
TLDR
Increased circulating estrogens and reduced androgen binding were found in moderately obese men, which were completely corrected with weight loss.
Reduced Fertility Among Overweight and Obese Men
TLDR
There was a dose–response relationship, and the BMI effect was stronger when the data were limited to couples with the highest-quality infertility data, suggesting that erectile dysfunction in older men does not explain the association.
Leptin and androgens in male obesity: evidence for leptin contribution to reduced androgen levels.
TLDR
Excess of circulating leptin may be an important contributor to the development of reduced androgen levels in male obesity, according to previous in vitro findings.
The decline of androgen levels in elderly men and its clinical and therapeutic implications.
TLDR
Until the long-term risk-benefit ratio for androgen administration to elderly is established in adequately powered trials of longer duration, androgen administrations to elderly men should be reserved for the minority of elderly men who have both clear clinical symptoms of hypogonadism and frankly low serum testosterone levels.
...
...